Blockchain Opportunities for Patient Data Donation ......Blockchain Opportunities for Patient Data...

Preview:

Citation preview

Blockchain Opportunities for Patient Data

Donation & Clinical Research

and Blockchain for Global Clinical Supply

Munther Baara, Sr. Director,

Head of New Clinical Paradigm, PfizerMarch 28h, 2019

Healthcare Blockchain 2019

Legal Disclaimer

2

This presentation outlines a general technology direction. Pfizer Inc. has

no obligation to pursue any approaches outlined in this presentation or to

develop or use any functionality mentioned in this presentation. The

technology strategy and possible future developments are subject to

change and may be changed at any time for any reason without notice.

The opinions expressed are those of the presenter and do not represent

the employer or other affiliations.

An individual’s health data is Fragmented

captured through personal health and fitness data and across multiple care providers in disparate electronic health records

Personalized Information – PDF file

4

Blood test results

PSA test

CRP test

“Thomas Goetz: It's Time to Redesign Medical Data.” YouTube, 27 Jan. 2011, youtu.be/bCGlWQnzDVE.

Personalized Information – re-imagined

5

“Thomas Goetz: It's Time to Redesign Medical Data.” YouTube, 27 Jan. 2011, youtu.be/bCGlWQnzDVE.

1PatientsLikeMe Survey

90% of Patients Are Willing to Donate Their Data to Support Medical Research1.

Connected health data

Securely exchange information and aggregate individuals health data from disparate systems (Electronic Health Records, lab results, genetics, self-reported, sensors, MRI, X-ray, radiologist

rater, pathologist, etc.), providing individuals a 360°view of their health data history in chronological order to proactively manage their health

Data Donation App (POC)

The Data Donation App addresses the challenge of an individual’s health

data being fragmented by securely aggregate and providing the

individual with a holistic view of their health. Putting the individual at the

controls of their own data and health and wellbeing

Activity

tracker

Settings

consent, EHR,

data donation,

and more

Interface to

EHR Data

Relevant events,

activities and

support circle

Matching

patient to trials

Care giver

support network

Blockchain for Health Data Exchange

Enable individuals to aggregate their health data in a secure, trusted, automated, and error-free way

Each party on a

Blockchain network has

access to the entire

ledger and its complete

history

Nothing can be deleted

or modified

Code that can be executed

alongside transactions,

autonomous execution,

self-auditing

Distributed Ledger

Immutable

Smart Contract

Consensus

Transparency

Security, Privacy and Compliance

Provenance

Autonomous

Trust

Establishes trust in trustless world

Providing un-hackable security

against those unauthorized to view the data

Data Donation and Participating in

Clinical Trials

Recommendations engine to clinical trials

Recommendations engine to clinical trialsAuthentication without identification

✔ ✔

✔ ✔✔

✔✔

✔ ✔

Recommendations engine to clinical trialsAuthentication without identification

Blockchain for Clinical Supply Chain

Optimizing a clinical supply chain in this environment requires redefining how a supply chain network operates. We believe that

traditional clinical supply chain planning and operating structures will need to evolve into digital clinical supply chain networks.

C L I N I C A L S U P P L Y C H A I N C H A L L E N G E S

The Clinical Supply Chain Ecosystem is Rife with Challenges

Complexity Inefficiency MistrustOpacity

T R A D I T I O N A L

C L I N I C A L S U P P LY C H A I N

Develop Plan Source Make Deliver Support

Transforming from a traditional clinical supply chain to a digital clinical supply network will be important

to meet current and future challenges. We believe that blockchain will be a critical enabler to realize digital

clinical supply chain networks.

H O W B L O C K C H A I N C A N H E L P

The Evolution of Clinical Supply Chains

D I G I TA L C L I N I C A L

S U P P LY N E T WO R K S ( D C S N )

Identify Record Report Future

Needs

Analytics

is to develop a fully interoperable, transparent and auditable platform that

enables Investigational Product (IP) to be tracked from point of manufacture to

the point of which it is consumed by the patient.

API

Manufacture

Drug

Product

Manufacture

Packaging &

Labeling

Warehousing Logistics Clinical Site

Operations

Patient

Consumption

Inputs

Clinical Supply BlockchainBlockchain

Capabilities

Regulators (e.g., FDA)

External

Partners (e.g., CMOs)

Pfizer

Stakeholders

P F I Z E R ’ S G L O B A L C L I N I C A L S U P P L Y V I S I O N F O R B L O C K C H A I N

Multi-Layer

Consumers

Data Hand

offs Among

Partners

Lack of Real

Time

Visibility

Compliance Traceability

Data

Provenance

Multi Party

AggregationRecord Keeping Digital IdentitySmart Contracts

Relevant Blockchain Capabil i t ies

Blockchain Technology Provides Key Capabilities to Address These Pain Points

Building the Foundation for an Industry Solution

P F I Z E R ’ S V I S I O N F O R B L O C K C H A I N

Near Term

Pfizer Foundational Model

Pfizer

Medium Term

Pfizer Proximity Model

Blockchain Industry

Long Term

Industry Wide Solution

Benefits yielded from the solution will come in phases as more participants are added to the blockchain network and as new and more substantial capabilities are activated

Pfizer’s Digital Landscape

A D I G I T A L W O R L D

Voice

Assistant

(e.g., Amazon

Alexa)

Internet of

Things

(IoT)

Unmanned

Aerial

Vehicle

Mobile Apps(e.g., Kit Verify,

Shipment

Notification)

Wearables

(e.g., Apple

Watch)

AI / Machine

Learning

GS1

Standard for

Clinical

Supplies

Imagine What the Future Could Be …

22

Imagine What the Future Could Be …

Rise of Digital Clinical Trials Precision Recommendations

to Patients

New Profit Sharing Models Realization of Gov programs

like MyHealthEData

Realization of P4 Medicine

New Artificial Intelligence

Models

To Make This Future Real, We Need to Bring the

Ecosystem Together

24

Regulators

People

Researchers

Providers

Payers

Thank You

For more information on this topic, please feel

free to download our whitepaper or reach out.

Munther Baara

munther.baara@pfizer.com

Craig Lipset

craig.lipset@pfizer.com

Aditya Kudumala

akudumala@deloitte.com

www.deloitte.com/us/clinical-blockchain

Recommended